Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    Glucose Levels Affect Total Joint Replacement Outcomes in Patients With Diabetes - (DGNews)
    Endocrine Society Responds to Insulin Glargine Studies With Recommendations - (DGNews)
    TopAbstracts in Diabetes 06/30/2009 - (DGNews)
    Certain Biomarkers Have Limitations in Predicting Cardiovascular Events - (DGNews)
    Glucose Challenge Test Is Accurate for Diabetes, Prediabetes Screening - (DGNews)

    News archive

     Recent webcasts/CME - Diabetes
    • Matching Treatment to Need in Type 2 Diabetes: Using Incretin-Based Oral Therapies Across the Clinical Spectrum
    • Achieving Glycemic Control After Standard Therapy Has Failed
    • The Challenge of Type 2 Diabetes: Emerging Options for Improving Glycemic Control
      Addressing Patient Challenges to Diabetes Treatment Through the Use of Incretin-based Therapies
      Management of Hyperglycemia in Acute-Care Settings and the Transition to Ambulatory Care

      Webcasts/CME archive

       Recent cases - Diabetes
        Improvement of the Diabetic Foot Upon Testosterone Administration to Hypogonadal Men with Peripheral Arterial Disease. Report of Three Cases
        Caudal Regression Syndrome and Popliteal Webbing in Connection with Maternal Diabetes Mellitus: A Case Report and Literature Review
        Atypical Onset of Diabetes in a Teenage Girl: A Case Report
        Painful Swelling in the Thigh: Diabetic Muscle Infarction
        Atypical Ketosis-Prone Diabetes

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Heavy Proteinuria May Speed Progression Of Diabetic Nephropathy

        A DGReview of :"Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy."
        Journal of Diabetes and its Complications

        01/13/2003
        By David Loshak


        Heavy proteinuria may quicken the progression of diabetic nephropathy, say researchers.

        The process may be a result of the increase in the expression of monocyte chemoattractant protein-1 in renal tubuli, say investigators at Akita University School of Medicine, Akita, Japan.

        Monocyte chemoattractant protein-1 is a chemokine which mediates renal interstitial inflammation, tubular atrophy and interstitial fibrosis. It does so by recruiting monocytes and macrophages into renal tubulointerstitium.

        The investigators noted that recent studies had shown that protein overload in renal tubular cells up-regulated monocyte chemoattractant protein-1 gene and its protein expression.

        They then put forward the idea that increased expression of monocyte chemoattractant protein-1 in renal tubuli, probably triggered by increased leakage of plasma protein from glomerular capillary to tubular fluid, might contribute to renal tubular damage and accelerate diabetic nephropathy.

        The investigators examined urinary excretion levels of monocyte chemoattractant protein-1and N-acetylglucosaminidase, a sensitive marker of renal tubular damage, in 72 Japanese Type II diabetic patients. Twenty nine had normoalbuminuria, 25 had microalbuminuria and 18 had macroalbuminuria.

        The median urinary excretion level of monocyte chemoattractant protein-1 in patients with macroalbuminuria was 394.4 ng/g creatinine, significantly higher than the levels in patients with normoalbuminuria (159.6 ng/g creatinine) and microalbuminuria (193.9 ng/g creatinine). Moreover, urinary monocyte chemoattractant protein-1 excretion level was positively correlated with urinary excretion levels of albumin and N-acetylglucosaminidase in all patients.

        The investigators said that these findings suggested that monocyte chemoattractant protein-1 was produced in renal tubular cells and released into urine in proportion to the degree of proteinuria (albuminuria).
        Journal of Diabetes and its Complications 2003;17(1):11-15. "Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send